| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | 0.38 | 0.02 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.02 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.12 | 0.02 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | 0.072 | 0.03 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | Crizotinib | CCLE | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | S-Trityl-L-cysteine | FIMM | pan-cancer | AAC | 0.38 | 0.03 |